US Broker Ratings

Waters Corporation (WAT) Stock Analysis: An Investor’s Guide to a 4.42% Potential Upside in the Healthcare Sector

Waters Corporation (WAT), a prominent player in the healthcare sector, is generating significant interest among investors with its robust revenue growth and solid analyst ratings. Operating within the diagnostics and..

Edwards Lifesciences (EW) Investor Outlook: A 11.78% Potential Upside in the Medical Device Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a significant player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $49.79 billion, this Irvine,..

HCA Healthcare, Inc. (HCA) Investor Outlook: Exploring a 34.98% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA), a leading player in the Medical Care Facilities industry, presents a compelling investment opportunity for those looking to capitalize on the healthcare sector. With a..

BioNTech SE (BNTX) Stock Analysis: Potential 29% Upside with Promising Oncology Pipeline

BioNTech SE (NASDAQ: BNTX) has become a household name, particularly following its pivotal role in developing one of the first mRNA vaccines for COVID-19. However, for investors, the real story..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 27.83% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to turn their attention to Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the drug manufacturing industry with a..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Veeva Systems Inc. (VEEV): A 50% Upside Potential in Health Information Services – Investor Outlook

Veeva Systems Inc. (NYSE: VEEV) is making waves in the Healthcare sector, particularly within the Health Information Services industry. With a robust market capitalization of $28.45 billion, Veeva is a..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector

Alcon Inc. (NYSE: ALC), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, continues to capture investor attention with its robust market presence and promising..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a leader in the healthcare plans industry, operates with a market capitalization of $85.39 billion, positioning itself as a formidable player within the U.S. healthcare..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 22.6% Potential Upside Amidst Robust Revenue Growth

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, continues to capture investor attention with its innovative approach to treating serious diseases. With a market capitalization of $113.59..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 47.63% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, with a market capitalization of $40.32 billion, reflecting its significant position in the healthcare industry. With..

CVS Health Corporation (CVS)

⚠️ No article content returned.

..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Ratings and Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, commands a significant presence in the global pharmaceutical industry. With a market capitalization of $293.22 billion, Merck stands..

Boston Scientific Corporation (BSX): Investor Outlook with a 64% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, is capturing investor attention with its strategic positioning in the medical devices industry. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Evaluating a Promising 20.91% Upside Potential

AstraZeneca PLC (AZN), a titan in the healthcare sector, holds a prominent position in the drug manufacturing industry. With a staggering market capitalization of $287.95 billion, this UK-based biopharmaceutical powerhouse..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 37% Upside Potential Amidst Healthcare Innovations

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, is capturing investor attention with its potential upside of 37.02%, as indicated by the current analyst average target price of..

UnitedHealth Group (UNH) Stock Analysis: Healthcare Giant with a 5.11% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, boasting a market capitalization of $345.38 billion. Operating primarily in the healthcare plans industry, UnitedHealth Group delivers..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating a 16% Upside Potential with Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, has remained a prominent force in the drug manufacturing industry since its inception in 2012. With a current market..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 36% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading name in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to healthcare innovation. With a market capitalization of $10.45 billion, the..

Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating a Potential 41.52% Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors with its robust pipeline of innovative cancer therapies and a notable potential upside of 41.52%. The clinical-stage biopharmaceutical company, based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds